1. JW Adlard NJ Bundredt 2006 Radiotherapy for ductal carcinoma in situ Clin Oncol (R Coll Radiol) 18 179 184.

1. JW Adlard NJ Bundredt 2006 Radiotherapy for ductal carcinoma in situ Clin Oncol (R Coll Radiol) 18 179 184.)| false
• Search Google Scholar
• Export Citation

2. M Amichetti O Caffo A Richetti et al.1999 Subclinical ductal carcinoma in situ of the breast: treatment with conservative surgery and radiotherapy Tumori 85 488 493.

2. M Amichetti O Caffo A Richetti 1999 Subclinical ductal carcinoma in situ of the breast: treatment with conservative surgery and radiotherapy Tumori 85 488 493.)| false
• Search Google Scholar
• Export Citation

3. H Bartelink JC Horiot PM Poortmans et al.2007 Impact of a higher radation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial J Clin Oncol 25 3259 3265.

3. H Bartelink JC Horiot PM Poortmans 2007 Impact of a higher radation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial J Clin Oncol 25 3259 3265.)| false
• Search Google Scholar
• Export Citation

4. N Bijker P Meijnen JL Peterse et al.2006 Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 – A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group J Clin Oncol 24 3381 3387.

4. N Bijker P Meijnen JL Peterse 2006 Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 – A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group J Clin Oncol 24 3381 3387.)| false
• Search Google Scholar
• Export Citation

5. J Boyages G Delaney R Taylor 1998 Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis Cancer 85 616 628.

5. J Boyages G Delaney R Taylor 1998 Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis Cancer 85 616 628.)| false
• Search Google Scholar
• Export Citation

6. Consensus Conference Committee 1997 Consensus Conference on the Classification of Ductal Carcinoma in Situ, April 25-28, 1997 Cancer 80 1798 1802.

6. Consensus Conference Committee 1997 Consensus Conference on the Classification of Ductal Carcinoma in Situ, April 25-28, 1997 Cancer 80 1798 1802.)| false
• Search Google Scholar
• Export Citation

7. DB Cornfield JP Palazzo GF Schwartz et al.2004 The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast – A study of a large cohort of patients treated with surgery alone Cancer 100 2317 2327.

7. DB Cornfield JP Palazzo GF Schwartz 2004 The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast – A study of a large cohort of patients treated with surgery alone Cancer 100 2317 2327.)| false
• Search Google Scholar
• Export Citation

8. J Cuzick 2003 Treatment for DCIS – results from clinical trials Surg Oncol 12 213 219.

8. J Cuzick 2003 Treatment for DCIS – results from clinical trials Surg Oncol 12 213 219.)| false
• Search Google Scholar
• Export Citation

9. Early Breast Cancer Trialists' Collaborative Group 2005 Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2087 2106.

9. Early Breast Cancer Trialists' Collaborative Group 2005 Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2087 2106.)| false
• Search Google Scholar
• Export Citation

10. SO Emdin B Granstrand A Ringberg et al.2006 DCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening Acta Oncol 45 536 543.

10. SO Emdin B Granstrand A Ringberg 2006 DCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening Acta Oncol 45 536 543.)| false
• Search Google Scholar
• Export Citation

11. R Fietkau 2004 Ductal carcinoma in situ of the breast: Increasing importance of radiotherapy as a part of the therapy approach Strahlenther Onkol 180 682 689.

11. R Fietkau 2004 Ductal carcinoma in situ of the breast: Increasing importance of radiotherapy as a part of the therapy approach Strahlenther Onkol 180 682 689.)| false
• Search Google Scholar
• Export Citation

12. B Fisher S Anderson J Bryant et al.2002 Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer New Engl J Med 347 1233 1241.

12. B Fisher S Anderson J Bryant 2002 Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer New Engl J Med 347 1233 1241.)| false
• Search Google Scholar
• Export Citation

13. B Fisher J Costantino C Redmond et al.1993 Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer New Engl J Med 328 1581 1586.

13. B Fisher J Costantino C Redmond 1993 Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer New Engl J Med 328 1581 1586.)| false
• Search Google Scholar
• Export Citation

14. B Fisher J Dignam N Wolmark et al.1999 Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial Lancet 353 1993 2000.

14. B Fisher J Dignam N Wolmark 1999 Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial Lancet 353 1993 2000.)| false
• Search Google Scholar
• Export Citation

15. B Fisher S Land E Mamounas et al.2001 Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience Semin Oncol 28 400 418.

15. B Fisher S Land E Mamounas 2001 Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience Semin Oncol 28 400 418.)| false
• Search Google Scholar
• Export Citation

16. ER Fisher J Dignam E Tan-Chiu et al.1999 Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17: Intraductal carcinoma Cancer 86 429 438.

16. ER Fisher J Dignam E Tan-Chiu 1999 Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17: Intraductal carcinoma Cancer 86 429 438.)| false
• Search Google Scholar
• Export Citation

17. J Fodor T Major Cs Polgár et al.1998 Az emlőrák lokális kiújulása emlőmegtartó műtét után: a sugárterápia értékelése Magyar Onkológia 42 225 228.

17. J Fodor T Major Cs Polgár 1998 Az emlőrák lokális kiújulása emlőmegtartó műtét után: a sugárterápia értékelése Magyar Onkológia 42 225 228.)| false
• Search Google Scholar
• Export Citation

18. J Fodor Cs Polgár G Németh 2000 Az operábilis emlőrák bizonyítékokon alapuló sugárkezelése: a 90-es évek eredményeinek elemzése Orvosi Hetilap 28 1551 1555.

18. J Fodor Cs Polgár G Németh 2000 Az operábilis emlőrák bizonyítékokon alapuló sugárkezelése: a 90-es évek eredményeinek elemzése Orvosi Hetilap 28 1551 1555.)| false
• Search Google Scholar
• Export Citation

19. TJ Hieken M Farolan S D'Alessandro et al.2001 Predicting the biologic behaviour of ductal carcinoma in situ: An analysis of molecular markers Surgery 130 593 601.

19. TJ Hieken M Farolan S D'Alessandro 2001 Predicting the biologic behaviour of ductal carcinoma in situ: An analysis of molecular markers Surgery 130 593 601.)| false
• Search Google Scholar
• Export Citation

20. J Houghton WD George J Cuzick et al.2003 Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial Lancet 362 95 102.

20. J Houghton WD George J Cuzick 2003 Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial Lancet 362 95 102.)| false
• Search Google Scholar
• Export Citation

21. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481.

21. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Assoc 53 457 481.)| false
• Search Google Scholar
• Export Citation

22. GD Leonard SM Swain 2004 Ductal carcinoma in situ, complexities and challanges J Natl Cancer Inst 96 906 920.

22. GD Leonard SM Swain 2004 Ductal carcinoma in situ, complexities and challanges J Natl Cancer Inst 96 906 920.)| false
• Search Google Scholar
• Export Citation

23. SG MacAusland JT Hepel FK Chong et al.2007 An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ Cancer 110 2648 2653.

23. SG MacAusland JT Hepel FK Chong 2007 An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ Cancer 110 2648 2653.)| false
• Search Google Scholar
• Export Citation

24. HR Macdonald MJ Silverstein LA Lee et al.2006 Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast Am J Surg 192 420 422.

24. HR Macdonald MJ Silverstein LA Lee 2006 Margin width as the sole determinant of local recurrence after breast conservation in patients with ductal carcinoma in situ of the breast Am J Surg 192 420 422.)| false
• Search Google Scholar
• Export Citation

25. I Mascarel F Bonichon G MacGrogan et al.2000 Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: Practical considerations Breast Cancer Res Treat 61 151 159.

25. I Mascarel F Bonichon G MacGrogan 2000 Application of the Van Nuys prognostic index in a retrospective series of 367 ductal carcinomas in situ of the breast examined by serial macroscopic sectioning: Practical considerations Breast Cancer Res Treat 61 151 159.)| false
• Search Google Scholar
• Export Citation

26. P Meijnen JL Peterse N Antonini et al.2008 Immunohistochemical categorisation of ductal carcinoma in situ of the breast Br J Cancer 98 137 142.

26. P Meijnen JL Peterse N Antonini 2008 Immunohistochemical categorisation of ductal carcinoma in situ of the breast Br J Cancer 98 137 142.)| false
• Search Google Scholar
• Export Citation

27. K Mokbel 2005 Contemporary treatment of ductal carcinoma in situ of the breast Med Sci Monit 11 86 93.

27. K Mokbel 2005 Contemporary treatment of ductal carcinoma in situ of the breast Med Sci Monit 11 86 93.)| false
• Search Google Scholar
• Export Citation

28. K Mokbel B Cutuli 2006 Heterogeneity of ductal carcinoma in situ and its effects on management Lancet Oncol 7 756 765.

28. K Mokbel B Cutuli 2006 Heterogeneity of ductal carcinoma in situ and its effects on management Lancet Oncol 7 756 765.)| false
• Search Google Scholar
• Export Citation

29. A Omlin M Amichetti D Azria et al.2006 Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network Lancet Oncol 7 652 656.

29. A Omlin M Amichetti D Azria 2006 Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network Lancet Oncol 7 652 656.)| false
• Search Google Scholar
• Export Citation

30. Zs Orosz N Jani Zs Kahán et al.2007 In situ ductalis emlőcarcinomák (DCIS) multicentrikus klinikopatológiai elemzése Magyar Onkológia 51 376.

30. Zs Orosz N Jani Zs Kahán 2007 In situ ductalis emlőcarcinomák (DCIS) multicentrikus klinikopatológiai elemzése Magyar Onkológia 51 376.)| false
• Search Google Scholar
• Export Citation

31. T Perin V Canzonieri S Massarut et al.1996 Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breast Eur J Cancer 32A 1148 1155.

31. T Perin V Canzonieri S Massarut 1996 Immunohistochemical evaluation of multiple biological markers in ductal carcinoma in situ of the breast Eur J Cancer 32A 1148 1155.)| false
• Search Google Scholar
• Export Citation

32. C Polgár J Fodor T Major et al.2001 The role of boost irradiation in the conservative treatment of stage I-II breast cancer Pathol Oncol Res 7 241 250.

32. C Polgár J Fodor T Major 2001 The role of boost irradiation in the conservative treatment of stage I-II breast cancer Pathol Oncol Res 7 241 250.)| false
• Search Google Scholar
• Export Citation

33. C Polgár J Fodor Z Orosz et al.2002 Electron and brachytherapy boost in the conservative treatment of stage I-II breast cancer: 5-year results of the randomized Budapest boost trial Radiother Oncol 64 Suppl 1 S15.

33. C Polgár J Fodor Z Orosz 2002 Electron and brachytherapy boost in the conservative treatment of stage I-II breast cancer: 5-year results of the randomized Budapest boost trial Radiother Oncol 64 Suppl 1 S15.)| false
• Search Google Scholar
• Export Citation

34. C Polgár J Fodor T Major et al.2007 Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma – 5-year results of a randomized trial Int J Radiat Oncol Biol Phys 69 694 702.

34. C Polgár J Fodor T Major 2007 Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma – 5-year results of a randomized trial Int J Radiat Oncol Biol Phys 69 694 702.)| false
• Search Google Scholar
• Export Citation

35. Cs Polgár J Fodor Gy Németh 2001 A korai emlőrák sugárkezelése: Több mint loko-regionális daganatkontroll Magyar Onkológia 45 361 371.

35. Cs Polgár J Fodor Gy Németh 2001 A korai emlőrák sugárkezelése: Több mint loko-regionális daganatkontroll Magyar Onkológia 45 361 371.)| false
• Search Google Scholar
• Export Citation

36. Cs Polgár J Fodor Zs Orosz et al.2001 A tumorágy kiegészítő besugárzásának hatása a lokális daganatmentességre emlőmegtartó műtét után: Az Országos Onkológiai Intézet randomizált “boost” vizsgálatának első eredményei Magyar Onkológia 45 385 391.

36. Cs Polgár J Fodor Zs Orosz 2001 A tumorágy kiegészítő besugárzásának hatása a lokális daganatmentességre emlőmegtartó műtét után: Az Országos Onkológiai Intézet randomizált “boost” vizsgálatának első eredményei Magyar Onkológia 45 385 391.)| false
• Search Google Scholar
• Export Citation

37. C Polgár V Strnad T Major 2005 Brachytherapy for partial breast irradiation: The European experience Semin Radiat Oncol 15 116 122.

37. C Polgár V Strnad T Major 2005 Brachytherapy for partial breast irradiation: The European experience Semin Radiat Oncol 15 116 122.)| false
• Search Google Scholar
• Export Citation

38. E Provenzano JL Hopper GG Giles et al.2003 Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast Eur J Cancer 39 622 630.

38. E Provenzano JL Hopper GG Giles 2003 Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast Eur J Cancer 39 622 630.)| false
• Search Google Scholar
• Export Citation

39. J Ragaz A Coldman 1998 Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes J Clin Oncol 16 2018 2024.

39. J Ragaz A Coldman 1998 Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes J Clin Oncol 16 2018 2024.)| false
• Search Google Scholar
• Export Citation

40. PB Rajan DJ Scott RH Perry et al.1997 p53 protein expression in ductal carcinoma in situ (DCIS) of the breast Breast Cancer Res Treat 42 283 290.

40. PB Rajan DJ Scott RH Perry 1997 p53 protein expression in ductal carcinoma in situ (DCIS) of the breast Breast Cancer Res Treat 42 283 290.)| false
• Search Google Scholar
• Export Citation

41. A Ringberg L Anagnostaki H Anderson et al.2001 Cell biological factors in ductal carcinoma in situ (DCIS) of the breast – relationship to ipsilateral local recurrence and histopathological characteristics Eur J Cancer 37 1514 1522.

41. A Ringberg L Anagnostaki H Anderson 2001 Cell biological factors in ductal carcinoma in situ (DCIS) of the breast – relationship to ipsilateral local recurrence and histopathological characteristics Eur J Cancer 37 1514 1522.)| false
• Search Google Scholar
• Export Citation

42. A Ringberg I Idvall M Fernö et al.2000 Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast Eur J Surg Oncol 26 444 451.

42. A Ringberg I Idvall M Fernö 2000 Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast Eur J Surg Oncol 26 444 451.)| false
• Search Google Scholar
• Export Citation

43. A Ringberg H Nordgren S Thorstensson et al.2007 Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast – Results from the Swedish randomised trial Eur J Cancer 43 291 298.

43. A Ringberg H Nordgren S Thorstensson 2007 Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast – Results from the Swedish randomised trial Eur J Cancer 43 291 298.)| false
• Search Google Scholar
• Export Citation

44. P Romestaing Y Lehingue C Carrie et al.1997 Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France J Clin Oncol 15 963 968.

44. P Romestaing Y Lehingue C Carrie 1997 Role of a 10-Gy boost in the conservative treatment of early breast cancer: Results of a randomized clinical trial in Lyon, France J Clin Oncol 15 963 968.)| false
• Search Google Scholar
• Export Citation

45. SJ Schnitt JR Harris BL Smith 1996 Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet Cancer 77 2189 2192.

45. SJ Schnitt JR Harris BL Smith 1996 Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet Cancer 77 2189 2192.)| false
• Search Google Scholar
• Export Citation

46. GF Schwartz LJ Solin IA Olivotto et al.2000 Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999 Cancer 88 946 954.

46. GF Schwartz LJ Solin IA Olivotto 2000 Consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999 Cancer 88 946 954.)| false
• Search Google Scholar
• Export Citation

47. MJ Silverstein 2002 The University of Southern California/Van Nuys Prognostic Index MJ Silverstein Ductal carcinoma in situ of the breast Lippincott Williams & Wilkins Philadelphia, USA 459 473.

47. MJ Silverstein 2002 The University of Southern California/Van Nuys Prognostic Index MJ Silverstein Ductal carcinoma in situ of the breast Lippincott Williams & Wilkins Philadelphia, USA 459 473.)| false
• Search Google Scholar
• Export Citation

48. MJ Silverstein 2002 The Van Nuys/University of Southern California experience by treatment MJ Silverstein Ductal carcinoma in situ of the breast Lippincott Williams & Wilkins Philadelphia, USA 337 342.

48. MJ Silverstein 2002 The Van Nuys/University of Southern California experience by treatment MJ Silverstein Ductal carcinoma in situ of the breast Lippincott Williams & Wilkins Philadelphia, USA 337 342.)| false
• Search Google Scholar
• Export Citation

49. MJ Silverstein MD Lagios PH Craig et al.1996 A prognostic index for ductal carcinoma in situ of the breast Cancer 77 2267 2274.

49. MJ Silverstein MD Lagios PH Craig 1996 A prognostic index for ductal carcinoma in situ of the breast Cancer 77 2267 2274.)| false
• Search Google Scholar
• Export Citation

50. MJ Silverstein MD Lagios S Groshen et al.1999 The influence of margin width on local control of ductal carcinoma in situ of the breast N Engl J Med 340 1455 1461.

50. MJ Silverstein MD Lagios S Groshen 1999 The influence of margin width on local control of ductal carcinoma in situ of the breast N Engl J Med 340 1455 1461.)| false
• Search Google Scholar
• Export Citation

51. MJ Silverstein DN Poller JR Waisman et al.1995 Prognostic classification of breast ductal carcinoma-in-situ Lancet 345 1154 1157.

51. MJ Silverstein DN Poller JR Waisman 1995 Prognostic classification of breast ductal carcinoma-in-situ Lancet 345 1154 1157.)| false
• Search Google Scholar
• Export Citation

52. WE Sumner LG Koniaris SE Snell et al.2007 Results of 23,810 cases of ductal carcinoma-in-situ Ann Surg Oncol 14 1638 1643.

52. WE Sumner LG Koniaris SE Snell 2007 Results of 23,810 cases of ductal carcinoma-in-situ Ann Surg Oncol 14 1638 1643.)| false
• Search Google Scholar
• Export Citation

53. C Vargas L Kestin N Go et al.2005 Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy Int J Radiat Oncol Biol Phys 63 1514 1521.

53. C Vargas L Kestin N Go 2005 Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy Int J Radiat Oncol Biol Phys 63 1514 1521.)| false
• Search Google Scholar
• Export Citation

54. U Veronesi N Cascinelli L Mariani et al.2002 Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer New Engl J Med 347 1227 1232.

54. U Veronesi N Cascinelli L Mariani 2002 Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer New Engl J Med 347 1227 1232.)| false
• Search Google Scholar
• Export Citation

55. GA Viani EJ Stefano SL Afonso et al.2007 Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials Rad Oncol 2 28.

55. GA Viani EJ Stefano SL Afonso 2007 Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials Rad Oncol 2 28.)| false
• Search Google Scholar
• Export Citation

56. JS Wong CM Kaelin SL Troyan et al.2006 Prospective study of wide excision alone for ductal carcinoma in situ of the breast J Clin Oncol 24 1031 1036.

56. JS Wong CM Kaelin SL Troyan 2006 Prospective study of wide excision alone for ductal carcinoma in situ of the breast J Clin Oncol 24 1031 1036.)| false
• Search Google Scholar
• Export Citation

57. F Zagouri TN Sergentanis GC Zografos 2007 Precursors and preinvasive lesions of the breast: the role of molecular prognostic factors in the diagnostic and therapeutic dilemma World J Surg Oncol 5 58.

57. F Zagouri TN Sergentanis GC Zografos 2007 Precursors and preinvasive lesions of the breast: the role of molecular prognostic factors in the diagnostic and therapeutic dilemma World J Surg Oncol 5 58.)| false
• Search Google Scholar
• Export Citation

58. K Zaugg S Bodis 2000 Is there a role for molecular prognostic factors in the clinical management of ductal carcinoma in situ (DCIS) of the breast Radiother Oncol 55 85 99.

58. K Zaugg S Bodis 2000 Is there a role for molecular prognostic factors in the clinical management of ductal carcinoma in situ (DCIS) of the breast Radiother Oncol 55 85 99.)| false
• Search Google Scholar
• Export Citation

59. Z Zhang H Yamashita T Toyama et al.2002 Semi-quantitative immuno-histochemical analysis of aromatase expression in ductal carcinoma in situ of the breast Breast Cancer Res Treat 74 47 53.

59. Z Zhang H Yamashita T Toyama 2002 Semi-quantitative immuno-histochemical analysis of aromatase expression in ductal carcinoma in situ of the breast Breast Cancer Res Treat 74 47 53.)| false
• Search Google Scholar
• Export Citation